{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:08:40Z","timestamp":1793124520761,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Alfred \u00d6sterlund Foundation","id":[{"id":"https:\/\/ror.org\/01wddqe20","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Medical Faculty of the University of Lund"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ekir.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T02:04:50Z","timestamp":1536804290000},"page":"67-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins"],"prefix":"10.1016","volume":"4","author":[{"given":"Markus S\u00e4llman","family":"Alm\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Bj\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Abrahamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnnaLotta Schiller","family":"Vestergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6rjan","family":"Lindhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Christensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Grubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2018.09.002_bib1","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","article-title":"Cardiovascular mortality risk in chronic kidney disease. Comparison of traditional and novel risk factors","volume":"293","author":"Shlipak","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2018.09.002_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/00365511003642535","article-title":"Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check","volume":"70","author":"Grubb","year":"2010","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00365513.2011.634023","article-title":"Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin C and eGFRcreatinine","volume":"72","author":"Grubb","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib4","series-title":"Biomarkers in Kidney Disease","first-page":"225","article-title":"Cystatin C as a multifaceted biomarker in kidney disease and its role in defining \u201cshrunken pore syndrome.\u201d","author":"Grubb","year":"2017"},{"key":"10.1016\/j.ekir.2018.09.002_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/00365513.2015.1025427","article-title":"Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: \u201cshrunken pore syndrome\u201d","volume":"75","author":"Grubb","year":"2015","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/00365513.2015.1099724","article-title":"Shrunken pore syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting","volume":"76","author":"Dardashti","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.trsl.2015.11.001","article-title":"The cystatin C\/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors","volume":"169","author":"Purde","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.ekir.2018.09.002_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/00365513.2016.1149882","article-title":"Ratio of cystatin C and creatinine-based estimates of the glomerular filtration rate predicts mortality in healthy seniors independent of kidney function","volume":"76","author":"Purde","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/00365513.2016.1223338","article-title":"The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population\u2014the HARVEST study","volume":"76","author":"Christensson","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ndt\/gfx004","article-title":"Measured glomerular filtration rate does not improve prediction of mortality by cystatin C and creatinine","volume":"32","author":"Sundin","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2018.09.002_bib11","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1373\/clinchem.2013.220707","article-title":"Generation of a new cystatin C-based estimating equation for glomerular filtration rate using seven assays standardized to the international calibrator","volume":"60","author":"Grubb","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.ekir.2018.09.002_bib12","first-page":"955","article-title":"Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate","volume":"104","author":"Krutz\u00e9n","year":"1984","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.ekir.2018.09.002_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","article-title":"Measuring GFR: a systematic review","volume":"64","author":"Soveri","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2018.09.002_bib14","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2018.09.002_bib15","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/clinchem\/40.10.1921","article-title":"Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate","volume":"40","author":"Kyhse-Andersen","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.ekir.2018.09.002_bib16","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1515\/CCLM.2010.318","article-title":"First certified reference material for cystatin C in human\u00a0serum ERM-DA471\/IFCC","volume":"48","author":"Grubb","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ekir.2018.09.002_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/cclm-2014-0578","article-title":"Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden","volume":"53","author":"Bj\u00f6rk","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ekir.2018.09.002_bib18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1515\/cclm-2013-0741","article-title":"The revised Lund-Malm\u00f6 GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population","volume":"52","author":"Nyman","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ekir.2018.09.002_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/00365513.2016.1183262","article-title":"Association of the cystatin C\/creatinine ratio with the renally cleared hormones parathyroid hormone (PTH) and brain natriuretic peptide (BNP) in primary care patients: a cross-sectional study","volume":"76","author":"Risch","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/00365517909108866","article-title":"Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system","volume":"39","author":"L\u00f6fberg","year":"1979","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.0954-6820.1985.tb08880.x","article-title":"Serum concentration of cystatin C, factor D and beta-2-microglobulin as a measure of glomerular filtration rate","volume":"218","author":"Grubb","year":"1985","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ekir.2018.09.002_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2018.09.002_bib23","first-page":"269","article-title":"Cystatin C is indispensable for evaluation of kidney disease","volume":"28","author":"Grubb","year":"2017","journal-title":"EJIFCC"},{"key":"10.1016\/j.ekir.2018.09.002_bib24","doi-asserted-by":"crossref","first-page":"e1700067","DOI":"10.1002\/prca.201700067","article-title":"The impact of the glomerular filtration rate on the human plasma proteome","volume":"12","author":"Christensson","year":"2018","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.ekir.2018.09.002_bib25","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000145166.44942.E0","article-title":"Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome","volume":"110","author":"Jernberg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2018.09.002_bib26","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2018.09.002_bib27","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2011.468","article-title":"Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality","volume":"305","author":"Peralta","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2018.09.002_bib28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2018.09.002_bib29","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","article-title":"Factors influencing cystatin C levels other than renal function and the impact on renal function measurement","volume":"65","author":"Knight","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.09.002_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00365513.2010.546879","article-title":"Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation","volume":"71","author":"Grubb","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib31","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1046\/j.1523-1755.2001.00016.x","article-title":"Glomerular protein sieving and implications for renal failure in Fanconi syndrome","volume":"60","author":"Norden","year":"2001","journal-title":"Kidney Int"},{"issue":"suppl","key":"10.1016\/j.ekir.2018.09.002_bib32","first-page":"S273","article-title":"Filtration quality: a new measure of renal disease","volume":"45","author":"Grubb","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ekir.2018.09.002_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/003655102753611771","article-title":"Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy","volume":"62","author":"Strevens","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib34","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/00365510701203488","article-title":"Temporal changes of the plasma levels of cystatin C, beta-trace protein, beta-2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process","volume":"67","author":"Kristensen","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/003655101753218346","article-title":"Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate","volume":"61","author":"Strevens","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib36","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/00016340701318133","article-title":"Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia","volume":"86","author":"Kristensen","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ekir.2018.09.002_bib37","first-page":"F338","article-title":"Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy","volume":"270","author":"Roberts","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ekir.2018.09.002_bib38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2011.04.002","article-title":"Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation","volume":"217","author":"Maddaluno","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2018.09.002_bib39","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/ATVBAHA.112.247262","article-title":"Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model","volume":"32","author":"Jin","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ekir.2018.09.002_bib40","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2018.09.002_bib41","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/01.ATV.20.11.2394","article-title":"Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis","volume":"11","author":"Dewberry","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ekir.2018.09.002_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CRD.0000000000000021","article-title":"Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy","volume":"3","author":"Hartman","year":"2014","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.ekir.2018.09.002_bib43","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1161\/01.CIR.0000148135.08582.97","article-title":"Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis","volume":"110","author":"Schieffer","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2018.09.002_bib44","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1161\/ATVBAHA.116.307892","article-title":"Smooth muscle cell-derived interleukin-17C plays an atherogenic role via the recruitment of proinflammatory interleukin-17A+ T cells to the aorta","volume":"36","author":"Butcher","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ekir.2018.09.002_bib45","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1172\/JCI115411","article-title":"Monocyte chemoattractant protein-1 in human atheromatous plaques","volume":"4","author":"Nelken","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2018.09.002_bib46","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1476-5381.2011.01660.x","article-title":"Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3","volume":"166","author":"Nedjai","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ekir.2018.09.002_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2011.03.015","article-title":"Interleukin 18 and coronary heart disease: prospective study and systematic review","volume":"217","author":"Jefferis","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2018.09.002_bib48","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2147\/DDDT.S72394","article-title":"CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions","volume":"8","author":"Akhavanpoor","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ekir.2018.09.002_bib49","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nm.3890","article-title":"Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter","volume":"7","author":"Wang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ekir.2018.09.002_bib50","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.metabol.2012.12.005","article-title":"Increased PD-1 on CD4(+)CD28(\u2212) T cell and soluble PD-1 ligand-1 in patients with T2DM: association with atherosclerotic macrovascular diseases","volume":"62","author":"Shi","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.ekir.2018.09.002_bib51","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4239\/wjd.v5.i5.678","article-title":"Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus","volume":"5","author":"Konya","year":"2014","journal-title":"World J Diabetes"},{"key":"10.1016\/j.ekir.2018.09.002_bib52","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5551\/jat.10.154","article-title":"Significance of serum circulating hepatocyte growth factor in the development of carotid atherosclerosis","volume":"10","author":"Kawamoto","year":"2003","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.ekir.2018.09.002_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12979-016-0080-1","article-title":"The inflammatory protein pentraxin 3 in cardiovascular disease","volume":"13","author":"Fornai","year":"2016","journal-title":"Immun Ageing"},{"key":"10.1016\/j.ekir.2018.09.002_bib54","doi-asserted-by":"crossref","unstructured":"van den Borne P, Quax PH, Hoefer IE, et\u00a0al. The multifaceted functions of CXCL10 in cardiovascular disease [e-pub ahead of print]. Biomed Res Int. https:\/\/doi.org\/10.1155\/2014\/893106, Accessed October 25, 2018.","DOI":"10.1155\/2014\/893106"},{"key":"10.1016\/j.ekir.2018.09.002_bib55","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.105.605121","article-title":"Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells","volume":"113","author":"Heller","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2018.09.002_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/bj20020435","article-title":"Oxidative stress increases eukaryotic initiation factor 4E phosphorylation in vascular cells","volume":"369","author":"Duncan","year":"2003","journal-title":"Biochem. J"},{"key":"10.1016\/j.ekir.2018.09.002_bib57","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2008.03.027","article-title":"Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis","volume":"202","author":"Li","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2018.09.002_bib58","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/ATVBAHA.111.235721","article-title":"CCL20 is increased in hypercholesterolemic subjects and is upregulated by LDL in vascular smooth muscle cells. Role of NF- kB","volume":"31","author":"Calvayrac","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ekir.2018.09.002_bib59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tcm.2012.04.003","article-title":"Regulation of atherogenesis by chemokine receptor CCR6","volume":"21","author":"Wan","year":"2011","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.ekir.2018.09.002_bib60","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCGENETICS.113.000456","article-title":"Adrenomedullin and arterial stiffness: integrative approach combining monocyte ADM expression, plasma MR-Pro-ADM, and genome-wide association study","volume":"7","author":"Beygui","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.ekir.2018.09.002_bib61","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.atherosclerosis.2014.07.026","article-title":"Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: a 4-year cohort study","volume":"236","author":"Rambod","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2018.09.002_bib62","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1177\/2047487317725017","article-title":"GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction","volume":"24","author":"Skau","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ekir.2018.09.002_bib63","doi-asserted-by":"crossref","unstructured":"Jin W, Zhao Y, Yan W, et\u00a0al. Elevated circulating interleukin-27 in patients with coronary artery disease is associated with dendritic cells, oxidized low-density lipoprotein, and severity of coronary artery stenosis [e-pub ahead of print]. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2012\/506283, Accessed October 25, 2018.","DOI":"10.1155\/2012\/506283"},{"key":"10.1016\/j.ekir.2018.09.002_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12872-016-0346-8","article-title":"Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes","volume":"16","author":"Gon\u00e7alves","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ekir.2018.09.002_bib65","first-page":"1270","article-title":"The role of hemostatic factors in atherosclerosis in patients with chronic renal disease","volume":"7","author":"Zahran","year":"2015","journal-title":"Electron Physician"},{"key":"10.1016\/j.ekir.2018.09.002_bib66","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jvs.2014.09.002","article-title":"Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease","volume":"61","author":"Martinez-Aguilar","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ekir.2018.09.002_bib67","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00011-011-0350-5","article-title":"Potential involvement of CCL23 in atherosclerotic lesion formation\/progression by the enhancement of chemotaxis, adhesion molecule expression, and MMP-2 release from monocytes","volume":"60","author":"Kim","year":"2011","journal-title":"Inflamm Res"},{"key":"10.1016\/j.ekir.2018.09.002_bib68","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1160\/TH09-01-0029","article-title":"The multi-functionality of CD40L and its receptor CD40 in atherosclerosis","volume":"102","author":"Lievens","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ekir.2018.09.002_bib69","doi-asserted-by":"crossref","first-page":"e43572","DOI":"10.1371\/journal.pone.0043572","article-title":"Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1","volume":"7","author":"Stolla","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2018.09.002_bib70","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1210\/en.2011-1282","article-title":"The osteoclast-associated receptor (OSCAR) is a novel receptor regulated by oxidized low-density lipoprotein in human endothelial cells","volume":"152","author":"Goettsch","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.ekir.2018.09.002_bib71","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2119\/molmed.2014.00004","article-title":"Human genetic evidence for involvement of CD137 in atherosclerosis","volume":"20","author":"S\u00f6derstr\u00f6m","year":"2014","journal-title":"Mol Med"},{"key":"10.1016\/j.ekir.2018.09.002_bib72","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.105.567297","article-title":"Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications","volume":"113","author":"Steffel","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2018.09.002_bib73","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2017.07.008","article-title":"Circulating soluble receptor for advanced glycation end product: cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes","volume":"264","author":"Wannamethee","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2018.09.002_bib74","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2018.09.002_bib75","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.kint.2016.10.021","article-title":"Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease","volume":"91","author":"Munoz Mendoza","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.09.002_bib76","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijcard.2015.03.151","article-title":"Prevalence of M4 macrophages within human coronary atherosclerotic plaques is associated with features of plaque instability","volume":"186","author":"Erbel","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ekir.2018.09.002_bib77","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1753425914526461","article-title":"CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in\u00a0vitro and in\u00a0vivo","volume":"21","author":"Erbel","year":"2015","journal-title":"Innate Immun"},{"key":"10.1016\/j.ekir.2018.09.002_bib78","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1741-7015-10-157","article-title":"Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography","volume":"10","author":"LaFramboise","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.ekir.2018.09.002_bib79","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/0004563215590451","article-title":"Lipoprotein lipase and atherosclerosis","volume":"52","author":"Kobayashi","year":"2015","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ekir.2018.09.002_bib80","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1006\/bbrc.2002.6720","article-title":"Increased plasma HB-EGF associated with obesity and coronary artery disease","volume":"292","author":"Matsumoto","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ekir.2018.09.002_bib81","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MCA.0b013e32833db539","article-title":"The role of heart-type fatty acid-binding protein in predicting properties of coronary atherosclerosis in patients with acute coronary syndrome","volume":"21","author":"Kalay","year":"2010","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.ekir.2018.09.002_bib82","doi-asserted-by":"crossref","first-page":"23496","DOI":"10.1074\/jbc.M110.117481","article-title":"Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis","volume":"285","author":"Abd Alla","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2018.09.002_bib83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2006.03.003","article-title":"Leptin and atherosclerosis","volume":"189","author":"Beltowski","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2018.09.002_bib84","first-page":"955","article-title":"Vascular endothelial growth factor-D is overexpressed in human cardiac allograft vasculopathy and diabetic atherosclerosis and induces endothelial permeability to low-density lipoproteins in\u00a0vitro","volume":"30","author":"Wong","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024918302006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024918302006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T13:47:27Z","timestamp":1604929647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024918302006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2468024918302006"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2018.09.002","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}